02/11/2023 - 17:50

Chimeric steps up fight against deadliest brain cancer

02/11/2023 - 17:50


Save articles for future reference.

Chimeric Therapeutics says it is a step closer to unlocking treatment hope for patients suffering from the world’s deadliest form of brain cancer after dosing its first patient as part of a phase-1B trial. The new trial comes on the back of positive survival results in the previous phase of testing as the company continues to tackle the devastating glioblastoma condition.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options